Detalhe da pesquisa
1.
Effective treatment of low-risk acute GVHD with itacitinib monotherapy.
Blood
; 141(5): 481-489, 2023 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36095841
2.
The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial.
Clin Infect Dis
; 78(1): 217-226, 2024 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37800415
3.
KIR-favorable TCR-αß/CD19-depleted haploidentical HCT in children with ALL/AML/MDS: primary analysis of the PTCTC ONC1401 trial.
Blood
; 140(24): 2556-2572, 2022 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35776909
4.
Metabolomic identification of α-ketoglutaric acid elevation in pediatric chronic graft-versus-host disease.
Blood
; 139(2): 287-299, 2022 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34534280
5.
Patient-reported treatment response in chronic graft-versus-host disease.
Haematologica
; 109(1): 143-150, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37226713
6.
A comprehensive assessment of the prolonged febrile neutropenia evaluation in pediatric oncology patients.
Pediatr Blood Cancer
; 71(3): e30818, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38110594
7.
Applying a risk prediction model for bloodstream infection in a febrile, nonseverely neutropenic cohort of pediatric stem cell transplant patients.
Cancer
; 129(10): 1591-1601, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36828805
8.
A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation.
Blood
; 137(7): 983-993, 2021 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33206937
9.
Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia.
Haematologica
; 108(3): 747-760, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36263840
10.
Children's Oncology Group's 2023 blueprint for research: Cellular therapy and stem cell transplantation.
Pediatr Blood Cancer
; 70 Suppl 6: e30577, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37480158
11.
Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies.
Blood
; 135(15): 1287-1298, 2020 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32047896
12.
The role of biomarkers in risk stratification, treatment and outcome in acute GVHD.
Curr Opin Hematol
; 28(6): 401-407, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34475350
13.
Influenza Vaccine in Pediatric Recipients of Hematopoietic-Cell Transplants.
N Engl J Med
; 388(4): 374-376, 2023 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36630610
14.
Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria.
Blood
; 134(3): 304-316, 2019 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31043425
15.
MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD.
Blood
; 131(25): 2846-2855, 2018 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29545329
16.
Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 18(1): 81-112, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31910389
17.
Early viral reactivation despite excellent immune reconstitution following haploidentical Bone marrow transplant with post-transplant cytoxan for sickle cell disease.
Transpl Infect Dis
; 22(1): e13222, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31782875
18.
Pericardial effusion following hematopoietic stem cell transplantation in children: Incidence, risk factors, and outcomes.
Pediatr Transplant
; 24(5): e13748, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32485042
19.
Mentors' perspectives on the successes and challenges of mentoring in the COG Young Investigator mentorship program: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 66(10): e27920, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31309744
20.
A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801.
Haematologica
; 103(11): 1915-1924, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29954931